Liposomal NAD+ Vitamin B3 Derivative 1000mg

NAD+ and cellular energy metabolism

Liposomal NAD+ Vitamin B3 Derivative 1000mg centres on nicotinamide adenine dinucleotide in its oxidised form. NAD+ is a dinucleotide coenzyme, rather than a peptide, and works with its reduced counterpart NADH in the reactions that help cells process energy.

Why NAD+ attracts research interest

Beyond its role in oxidation-reduction reactions, NAD+ is used by enzyme systems involved in cellular signalling and DNA-damage responses. Researchers therefore investigate both the regulation of NAD availability and the effects of changing NAD metabolism in different tissues.

NAD+ is distinct from nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN), which are precursors the body can use to make it. Human precursor studies have reported increases in blood NAD-related measurements, helping develop methods for studying this metabolic system.

Exploring liposomal delivery

A 2025 study of a particular liposomal NAD+ formulation reported cellular responses and improved penetration in excised skin. A short 2026 human trial also investigated a separately engineered oral NAD+ formulation. These are useful developments in delivery research, but their findings are formulation-specific.

The 1000mg product designation is retained as supplied. Product-specific evidence would be needed to establish its absorption advantage or clinical effects; a coenzyme's biological role alone does not prove a benefit from a finished supplement.

Also known as / branded as

• NAD+
• NAD⁺
• Nicotinamide adenine dinucleotide (oxidised form)